BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2566883)

  • 21. 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor.
    Bowenkamp KE; David D; Lapchak PL; Henry MA; Granholm AC; Hoffer BJ; Mahalik TJ
    Exp Brain Res; 1996 Sep; 111(1):1-7. PubMed ID: 8891630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
    Iwata SI; Nomoto M; Fukuda T
    Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of tyrosine hydroxylase and its mRNA in the rat substantia nigra pars reticulata by diazepam and picrotoxin.
    Stork O; Hashimoto T; Obata K
    Neurosci Res; 1994 Feb; 19(1):73-80. PubMed ID: 7911985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
    Weiss-Wunder LT; Chesselet MF
    Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of intraventricularly administered BMP-7 following a striatal 6-hydroxydopamine lesion.
    Zuch CL; David D; Ujhelyi L; Hudson JL; Gerhardt GA; Kaplan PL; Bickford PC
    Brain Res; 2004 Jun; 1010(1-2):10-6. PubMed ID: 15126112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM; Gash DM
    Brain Res; 1995 Feb; 672(1-2):104-11. PubMed ID: 7749731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine hydroxylase mRNA in the dopaminergic neurons of young adult and aged mice by in situ hybridization.
    Gupta M; Stoler MH; Fossom LH; Tank AW
    Neurosci Lett; 1990 Oct; 119(1):49-52. PubMed ID: 1982959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.
    Ferraz AC; Xavier LL; Hernandes S; Sulzbach M; Viola GG; Anselmo-Franci JA; Achaval M; Da Cunha C
    Brain Res; 2003 Oct; 986(1-2):200-5. PubMed ID: 12965246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.
    Romero J; Berrendero F; Pérez-Rosado A; Manzanares J; Rojo A; Fernández-Ruiz JJ; de Yebenes JG; Ramos JA
    Life Sci; 2000; 66(6):485-94. PubMed ID: 10794065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway.
    Aliaga E; Cárcamo C; Abarca J; Tapia-Arancibia L; Bustos G
    Brain Res Mol Brain Res; 2000 Jun; 79(1-2):150-5. PubMed ID: 10925152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration.
    Cottingham SL; Pickar D; Shimotake TK; Montpied P; Paul SM; Crawley JN
    Cell Mol Neurobiol; 1990 Mar; 10(1):41-50. PubMed ID: 1970757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra.
    Bing G; Zhang Y; Watanabe Y; McEwen BS; Stone EA
    Brain Res; 1994 Dec; 668(1-2):261-5. PubMed ID: 7704612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
    Kastner A; Hirsch EC; Agid Y; Javoy-Agid F
    Brain Res; 1993 Mar; 606(2):341-5. PubMed ID: 8098254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
    Penit-Soria J; Durand C; Herve D; Besson MJ
    Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of aging on the dopaminergic neurons in the substantia nigra pars compacta of rats.
    Gao J; Miao H; Xiao CH; Sun Y; Du X; Yuan HH; Yu HL; Gao DS
    Curr Aging Sci; 2011 Feb; 4(1):19-24. PubMed ID: 21204780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviour.
    Skutella T; Schwarting RK; Huston JP; Sillaber I; Probst JC; Holsboer F; Spanagel R
    Eur J Neurosci; 1997 Feb; 9(2):210-20. PubMed ID: 9058042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.